DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Dent R, Im SA, Espie M. et al.
Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC).

J Clin Oncol 2018;
36 (Suppl.) Abstr.. 1008

Download Bibliographical Data

Search in:
Access: